Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Revenue

In the year 2024, Biotechnology Assets had annual revenue of 2.97M EUR, down -24.13%. Biotechnology Assets had revenue of 1.86M in the half year ending December 31, 2024, with 3.34% growth.

• Revenue: 2.97M
• Revenue Growth: -24.13%
• P/S Ratio: 8.20
• Revenue / Employee: 87.21K
• Employees: 34
• Market Cap: 24.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.97M	-943.29K	-24.13%
Dec 31, 2023	3.91M	950.58K	32.14%
Dec 31, 2022	2.96M	-324.07K	-9.87%
Dec 31, 2021	3.28M	390.31K	13.50%
Dec 31, 2020	2.89M	-345.59K	-10.68%